compounded tirzepatide ending Online Prescription for Weight Loss FDA sets tirzepatide compounding deadlines

R.LeeC.-H.LeeA.-Y

P.SlatteryJ

doi: 10.3389/fddev.2024.1364037 Received 01 January 2024 Accepted 24 July 2024 Published 13 September 2024 Volume 4 - 2024 Edited by Ana Fortuna, University of Coimbra, Portugal Reviewed by James Meabon, United States Department of Veterans Affairs, United States Joana Gonalves, University of Coimbra, Portugal Elizabeth Hernndez-Echeagaray, National Autonomous University of Mexico, Mexico Updates Copyright 2024 Grados, Salehi, Lotfi, Dua and Xie

The study population included patients with a high disease burden at baseline and an average BMI of 37.6 kg/m2 across both arms

Biochemical and Biophysical Research Communications, 481 , 6370